Drug recall · November 21, 2018
Metoprolol Tartrate Injection recall
Why: Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00
- Lots / codes
Lot #: A0A0253, Exp. 02/2019; Lot #: B0369427-112717, Exp. 08/2019
- Quantity
- 1 vial
- Company
- RemedyRepack Inc., Indiana, PA
- Distribution
- 1 vial was distributed to a medical facility in Mayville, NY.
- Initiated
- October 26, 2018 · Voluntary: Firm initiated
- Classified
- November 14, 2018
- Reported
- November 21, 2018
- Ended
- February 5, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoprolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.